TFF Pharmaceuticals(TFFP)
2.00 0.01 0.5%
| 今开：1.96 | 昨收：1.99 |
| 最高：2.02 | 最低：1.9 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6196268.0 |
TFF Pharmaceuticals的热门讨论
招股说明书
TFF Pharmaceuticals(TFFP)04-19 05:25
$TFF Pharmaceuticals(TFFP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-034178 Act: 33 Size: 496 KB 网页链接查看全文
当期报告
TFF Pharmaceuticals(TFFP)05-03 05:15
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001213900-24-039213 Act: 34 Size: 915 KB 网页链接查看全文
超过5%股东持股披露
TFF Pharmaceuticals(TFFP)05-09 05:15
$TFF Pharmaceuticals(TFFP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-040937 Act: 34 Size: 107 KB 网页链接查看全文
持股变动声明
TFF Pharmaceuticals(TFFP)04-23 08:55
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035079 Size: 8 KB 网页链接查看全文
持股变动声明
TFF Pharmaceuticals(TFFP)04-23 08:55
$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035077 Size: 6 KB 网页链接查看全文
股东委托书协议
TFF Pharmaceuticals(TFFP)04-23 04:25
$TFF Pharmaceuticals(TFFP)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-24-034929 Act: 34 Size: 1 MB 网页链接查看全文
当期报告
TFF Pharmaceuticals(TFFP)07-01 18:05
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 5.02 Accession Number: 0001213900-24-057380 Act: 34 Size: 198 KB 网页链接查看全文
其他
TFF Pharmaceuticals(TFFP)04-23 04:25
$TFF Pharmaceuticals(TFFP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-034931 Act: 34 Size: 1 MB 网页链接查看全文
招股说明书「补充」
TFF Pharmaceuticals(TFFP)04-26 04:35
$TFF Pharmaceuticals(TFFP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-036239 Act: 33 Size: 1 MB 网页链接查看全文
招股说明书「补充」
TFF Pharmaceuticals(TFFP)04-29 19:25
$TFF Pharmaceuticals(TFFP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-036819 Act: 33 Size: 628 KB 网页链接查看全文
TFF Pharmaceuticals的最新讨论
Bio News |TFF Pharmaceuticals和Catalent合作开发可吸入药物使用的干粉制剂
牛股小红书2022-03-02 12:13
3月1日，$TFF Pharmaceuticals(TFFP)$ 和$Catalent(CTLT)$ 合作，采用前者专有的薄膜冷冻技术，测试和制造用于一系列生物疗法的干粉制剂。
根据该协议，Catalent将向TFF提供其扩大规模的专业知识和制造能力，作为其首选的开发和制造合作伙伴，Catalent将能够向其客户提供TFF技术，这有可能增加...查看全文
美港电讯APP2020-09-24 21:21
TFF制药(TFFP.O)：在实验中，发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆，公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ （来自美港电讯APP）查看全文
![[俏皮]](http://js.xueqiu.com/ugc/images/face/emoji_04_cool.png?v=1 "[俏皮]"){kind=small}
chuminhua2020-08-14 10:55
8月13日，TFF Pharmaceuticals，Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司，专注于根据其专利的薄膜冷冻（TFF）技术平台开发和商业化创新药物产品，宣布已与UNION therapeutics签订了一项全球独家许可协议，将其TFF技术与氯硝柳胺（niclosamide）联合使用。根据协议条款，UNI...查看全文
TFF Pharmaceuticals的公告
年度财报
$TFF Pharmaceuticals(TFFP)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-22-014844 Act: 34 Size: 5 MB 网页链接
当期报告
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001213900-22-014839 Act: 34 Size: 7 MB 网页链接
超过5%股东持股披露「修订」
$TFF Pharmaceuticals(TFFP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-022737 Act: 34 Size: 90 KB 网页链接
超过5%股东持股披露「修订」
$TFF Pharmaceuticals(TFFP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-041304 Act: 34 Size: 32 KB 网页链接
超过5%股东持股披露「修订」
$TFF Pharmaceuticals(TFFP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-021702 Act: 34 Size: 52 KB 网页链接
员工持股计划
$TFF Pharmaceuticals(TFFP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-21-067555 Act: 33 Size: 121 KB 网页链接
当期报告
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-21-066714 Act: 34 Size: 6 MB 网页链接
当期报告
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-21-059594 Act: 34 Size: 325 KB 网页链接
季度财报
$TFF Pharmaceuticals(TFFP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-21-059329 Act: 34 Size: 2 MB 网页链接
当期报告
$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 5.07 Accession Number: 0001213900-21-058147 Act: 34 Size: 215 KB 网页链接